Anti-inflammatory effects of opioids.

作者: Judith S Walker , None

DOI:

关键词:

摘要: In summary, therapy with opioids is an exciting new development for arthritis especially since there the potential fewer side effects from molecules which act outside CNS. We found kappa-opioid drugs to be powerfully anti-inflammatory, reducing disease severity by as much 80%; attenuating in a dose-dependent, stereoselective, antagonist-reversible manner. By contrast acting at other receptors were only therapeutic near toxic doses. The HPA-axis was partially involved, thus we investigated neural and immune mechanisms. Results showed that anti-inflammatory actions exerted via (i) reduced adhesion molecule expression; (ii) inhibition of cell trafficking; (iii) TNF release expression (iv) alterations mRNA protein levels SP CGRP joint tissue (Fig. 2). ability kappa-opioids multiple sites inflammatory cascade, suggested presence opioid various locations throughout may explain their powerful It also relevant during states enhanced peripherally directed axonal transport leads receptor upregulation on peripheral nerve terminals joint. Neuropeptides (SP CGRP) involved later phases adjuvant suggesting they are maintenance or persistence disease. involvement efficacy neurokinin-1 receptors) antagonists predicts combined opioid- has promise. Kappa-opioids are, however, onset. Thus, most likely exert changes cellular activation cytokine expression. mechanisms summarized Fig. 2. increased potency females significant advantage treatment these agents. Thus our work supports findings Stein's group, do indeed have periphery specific site. Peripherally prove potent rheumatoid sufferers future.

参考文章(38)
T Reisine, Opioid analgesics and antagonists Goodman & Gilman's The pharmacological basis of therapeutics. ,(1996)
Waltraud Binder, Caroline Scott, Judith S. Walker, Involvement of substance P in the anti-inflammatory effects of the peripherally selective kappa-opioid asimadoline and the NK1 antagonist GR205171. European Journal of Neuroscience. ,vol. 11, pp. 2065- 2072 ,(1999) , 10.1046/J.1460-9568.1999.00625.X
Richard J. Knapp, Ewa Malatynska, Nathan Collins, Lei Fang, Jean Y. Wang, Victor J. Hruby, William R. Roeske, Henry I. Yamamura, Molecular biology and pharmacology of cloned opioid receptors. The FASEB Journal. ,vol. 9, pp. 516- 525 ,(1995) , 10.1096/FASEBJ.9.7.7737460
Michael Ohh, Fumio Takei, New insights into the regulation of ICAM-1 gene expression. Leukemia & Lymphoma. ,vol. 20, pp. 223- 228 ,(1996) , 10.3109/10428199609051611
Zoltan Szekanecz, G. Kenneth Haines, Theodore R. Lin, Lisa A. Harlow, Sergij Goerdt, Ghazi Rayan, Alisa E. Koch, Differential distribution of intercellular adhesion molecules (ICAM-1, ICAM-2, and ICAM-3) and the MS-1 antigen in normal and diseased human synovia: Their possible pathogenetic and clinical significance in rheumatoid arthritis Arthritis & Rheumatism. ,vol. 37, pp. 221- 231 ,(1994) , 10.1002/ART.1780370211
R Likar, R Sittl, K Gragger, W Pipam, H Blatnig, C Breschan, V H. Schalk, C Stein, M Schäfer, Peripheral morphine analgesia in dental surgery Pain. ,vol. 76, pp. 145- 150 ,(1998) , 10.1016/S0304-3959(98)00036-0
Eija Kalso, Martin R Tramèr, Dawn Carroll, Henry J McQuay, Andrew R. Moore, Pain relief from intra-articular morphine after knee surgery: a qualitative systematic review. Pain. ,vol. 71, pp. 127- 134 ,(1997) , 10.1016/S0304-3959(97)03344-7
D. J. J. Carr, The Role of Endogenous Opioids and Their Receptors in the Immune System Experimental Biology and Medicine. ,vol. 198, pp. 710- 720 ,(1991) , 10.3181/00379727-198-43309B
Burt M Sharp, Sabita Roy, Jean M Bidlack, Evidence for opioid receptors on cells involved in host defense and the immune system Journal of Neuroimmunology. ,vol. 83, pp. 45- 56 ,(1998) , 10.1016/S0165-5728(97)00220-8